Suppr超能文献

三叶榕和海桑对链脲佐菌素诱导的糖尿病大鼠的降血糖、抗氧化和抗细胞凋亡作用。

Antihyperglycemic, Antioxidant and Antiapoptotic Effect of Rhizophora Mucronata and Avicennia Marina in Streptozotocin-induced Diabetic Rats.

机构信息

Department of Biological Sciences, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.

Princess Dr. Najla Bint Saud Al-Saud Center for Excellence Research in Biotechnology, King Abdulaziz University, Jeddah, Saudi Arabia.

出版信息

Med Arch. 2020 Dec;74(6):421-427. doi: 10.5455/medarh.2020.74.421-427.

Abstract

INTRODUCTION

Diabetes mellitus is a common disease worldwide. It is considered as the third leading cause of death, in the developed countries followed by heart diseases and cancer.

AIM

The aim of this study was to assess the effectiveness of the aqueous fraction of R. mucronata and A. marina leaves grown in Saudi Arabia alone or in combination as antidiabetic agents and explore its effect on the antioxidants status.

METHODS

One hundred and twenty male Wistar albino rats were divided into 8 groups were utilized in this study. Streptozotocin (STZ) was utilized for induction of diabetes. The effects of daily oral administration of aqueous extract from the leaves of R. mucronata (400 mg/kg BW), A. marina (400 mg/kg BW) and the combination of both plant extracts for 6 weeks were evaluated on blood glucose, insulin, tissues' antioxidants as well as pancreatic immunohistochemistry in normal, (STZ)-induced diabetic rats.

RESULTS

Oral administration of the plants extracts significantly reduced (p ≤ 0.001) serum glucose, insulin and improved the antioxidants status in the liver compared to the untreated rats. Immunohistochemically, the pancreas of diabetic rats treated with R. mucronata revealed a few islets β-cells (2-3%/ HPF) with positive caspase-3.

CONCLUSION

The extract of R. mucronata exhibited a promising antidiabetic, antioxidant and tissue enhancing effects compared with A. marina alone or in combination.

摘要

简介

糖尿病是一种全球性的常见疾病。在发达国家,它被认为是继心脏病和癌症之后的第三大致死原因。

目的

本研究旨在评估在沙特阿拉伯种植的 R. mucronata 和 A. marina 叶的水提物单独或联合作为抗糖尿病药物的有效性,并探讨其对抗氧化剂状态的影响。

方法

本研究共使用了 120 只雄性 Wistar 白化大鼠,将其分为 8 组。采用链脲佐菌素(STZ)诱导糖尿病。评估了每天口服 R. mucronata(400mg/kgBW)、A. marina(400mg/kgBW)叶的水提取物以及两者联合应用 6 周对正常(STZ)诱导的糖尿病大鼠血糖、胰岛素、组织抗氧化剂以及胰腺免疫组织化学的影响。

结果

与未治疗的大鼠相比,植物提取物的口服给药显著降低(p≤0.001)血清葡萄糖、胰岛素,并改善肝脏的抗氧化状态。免疫组织化学显示,用 R. mucronata 治疗的糖尿病大鼠的胰腺中β细胞胰岛(2-3%/HPF)有少量 caspase-3 阳性。

结论

与单独使用 A. marina 或联合使用相比,R. mucronata 的提取物表现出有希望的抗糖尿病、抗氧化和组织增强作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c86/7879346/e52e9f4f7fcb/medarch-74-421-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验